Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07244939 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cephea South America Feasibility Study

Name: Cephea South America Feasibility Study — clinical trial record (NCT07244939)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusActive, Not Recruiting

PhaseNot applicable

SponsorAbbott Medical Devices

Started2025-06-17

View on ClinicalTrials.gov ↗

Amendment history

2026-09-10

Study Status, Contacts/Locations v2

Enrollment closed, study ongoing

Study sitesdetails revised at 3 of 3 sites

2026-02-05

Study Status, Contacts/Locations v1

Re-verified, no change to tracked fields

2025-11-17

Original filing

Abbott Medical Devices

84 trials monitored

See 2 trials at risk

The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is deemed more appropriate than open heart surgery.

Trial Details

NCT Number	NCT07244939
Lead Sponsor	Abbott Medical Devices
Conditions	Mitral Regurgitation, Mitral Stenosis
Enrollment	20 participants
Start Date	2025-06-17
Primary Completion	2026-09 (estimated)
Study Completion	2028-09 (estimated)
Updated on ClinicalTrials.gov	2026-09-11